Fibrin D-dimer, tissue-type plasminogen activator, von willebrand factor, and risk of incident stroke in older men

Stroke

Volumn 43, Issue 5, 2012, Pages 1206-1211

  Wannamethee, S Goya ^a   Whincup, Peter H ^b   Lennon, Lucy ^a   Rumley, Ann ^c   Lowe, Gordon D ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cerebrovascular disease; Epidemiology; Etiology; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; D DIMER; FIBRIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGED; AGING; ARTICLE; BLOOD CLOTTING; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FIBRINOLYSIS; FOLLOW UP; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEN'S HEALTH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; RISK FACTOR; RISK REDUCTION; STROKE;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

EID: 84860219054     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.636373     Document Type: Article

References (31)

1. Whincup PH, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, et al. von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J. 2002;23:1764-1770. (Pubitemid 35334269)
2. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation. 2001;103:2323-2327. (Pubitemid 32448793)
3. Lowe GD, Danesh J, Lewington S, Walker M, Lennon L, Thomson A, et al. Tissue plasminogen activator antigen and coronary heart disease: prospective study and meta-analysis. Eur Heart J. 2004;25:252-259. (Pubitemid 38235163)
4. Matijevic N, Wu KK. Hypercoagulable states and strokes. Curr Atheroscler Rep. 2006;8:324-329. (Pubitemid 44043651)
5. Qizilbash N, Duffy S, Prentice CR, Boothby M, Warlow C. Von Willebrand factor and risk of ischemic stroke. Neurology. 1997;49: 1552-1556. (Pubitemid 28015116)
6. Stott DJ, Spilg E, Campbell AM, Rumley A, Mansoor MA, Lowe GDO. Haemostasis in ishaemic stroke and vascular dementia. Blood Coagul Fibrinolys. 2001;12:651-657. (Pubitemid 33139684)
7. Hanson E, Jood K, Karlsson S, Nilsson S, Blomstrand C, Jern C. Plasma levels of von Willebrand factor in the etiologic subtypes of ischemic stroke. J Thromb Haemost. 2011;9:275-281.
8. Bongers TN, de Maat MP, van Goor ML, Bhagwanbali V, van Vliet HH, Gómez García EB, et al. High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Stroke. 2006;37:2672-2677. (Pubitemid 44922524)
9. Wieberdink RG, van Schie MC, Koudstaal PJ, Hofman A, Witteman JCM, de Maat MPM, et al. High von Willebrand factor levels increase the risk of stroke: The Rotterdam Study. Stroke. 2010;42:2151-2156.
10. Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ, et al. Prospective study of markers of hemostatic function with risk of ischaemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation. 1999;100:736-742. (Pubitemid 29383644)
11. Carcaillon L, Gaussem P, Ducimetiere P, Giroud M, Ritchie K, Dartigues JF, et al. Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort Study. J Thromb Haemost. 2009; 1972-1978.
12. Johansson L, Jansson JH, Boman K, Nilsson TK, Stegmayr B, Hallmans G. Prospective study on soluble thrombomodulin and von Willebrand factor and the risk of ischaemic and hemorrhagic stroke. Thromb Haemost. 2002;87:211-217. (Pubitemid 34139855)
13. Smith FB, Lee AJ, Fowkes FG, Rumley A, Lowe GD. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol. 1997;17:3321-3325. (Pubitemid 28016094)
14. Smith A, Patterson C, Yarnell J, Rumley A, Ben-Shlomo Y, Lowe G. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischaemic stroke? The Caerphilly Study. Circulation. 2005;112:3080-3087. (Pubitemid 43113439)
15. Lindgren A, Lindoff C, Norrving B, Astedt B, Johansson BB. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients. Stroke. 1996;27:1066-1071. (Pubitemid 26177608)
16. Whiteley W, Wardlaw J, Dennis M, Lowe G, Rumley A, Sattar N, Welsh P, et al. Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study. Cerebrovasc Dis. 2011;32:141-147.
17. Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet. 1994;343:940-943. (Pubitemid 24117228)
18. Johansson L, Jansson JH, Boman K, Nilsson TK, Stegmayr B, Hallmans G. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke. Stroke. 2000;31: 26-32. (Pubitemid 30035748)
19. Rumley A, Emberson JR, Wannamethee SG, Lennon L, Whincup PH, Lowe GD. Effects of older age on fibrin D-dimer, C-reactive protein, and other hemostatic and inflammatory variables in men aged 60-79 years. J Thromb Haemost. 2006;4:982-987.
20. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke. 2003;34:2518-2532. (Pubitemid 37221976)
21. Shaper AG, Pocock SJ, Walker M, Cohen NM, Wale CJ, Thomson AG. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ. 1981;283:179-186. (Pubitemid 11071686)
22. Macfarlane PW, Devine B, Latif S, McLaughlin S, Shoat DB, Watts MP. Methodology of ECG interpretation in the Glasgow program. Methods Inf Med. 1990;29:354-361. (Pubitemid 20311458)
23. Sadanaga T, Sadanaga M, Ogawa S. Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy. J Am Coll Cardiol. 2010;55:2225-2231.
24. Wannamethee SG, Lowe GD, Whincup PH, Rumley A, Walker M, Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation. 2002;105:1785-1790. (Pubitemid 34408887)
25. Emberson JR, Whincup PH, Walker M, Thomas M, Alberti KG. Biochemical measures in a population-based study: the effect of fasting duration and time of day. Ann Clin Biochem. 2002;39:493-501. (Pubitemid 34983445)
26. Wannamethee SG, Whincup PH, Shaper AG, Rumley A, Lennon L, Lowe GD. Circulating inflammatory and haemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. J Throm Haemostasis. 2009;7:1605-1611.
27. Vagaonescu TD, Wilson AC, Kostis JB. Atrial fibrillation and isolated systolic hypertension: the systolic hypertension in the elderly program and systolic hypertension in the elderly program-extension study. Hypertension. 2008;51:1552-1556.
28. Walker M, Shaper AG, Lennon L, Whincup PH. Twenty year follow-up of a cohort study based in general practices in 24 British towns. J Publ Hlth Med. 2000;22:479-485. (Pubitemid 32064892)
29. Kerr R, Stirling D, Ludlam CA. Interleukin 6 and haemostasis. Br J Haematol. 2001;115:3-12. (Pubitemid 32995086)
30. Catena C, Novello M, Lapenna R, Baroselli S, Colussi G, Nadalini E, Favret G, Cavarape A, Soardo G, Sechi LA. New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein( a). J Hypertens. 2005;23:1617-1631. (Pubitemid 41233418)
31. Sandercock PA, Warlow CP, Jones LN, Starkey IR. Predisposing factors for cerebral infarction: the Oxfordshire community stroke project. BMJ. 1989;298:75-80. (Pubitemid 19032928)